Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Cohen

Showing results (221-230 of 245) with videos related to

Pageof 25
Sort By:
The Journal of Clinical Endocrinology and Metabolism|June 1, 1984
The metabolic effects of biosynthetic human proinsulin in individuals with type I diabetesR M Bergenstal, R M Cohen, E Lever, et al.
Biological Psychiatry|August 1, 1994
Right frontotemporal activation by tonal memory in dyslexia, an O15 PET StudyJ M Rumsey, P Andreason, A J Zametkin, et al.
The New England Journal of Medicine|October 20, 1994
Estrogen resistance caused by a mutation in the estrogen-receptor gene in a manE P Smith, J Boyd, G R Frank, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1989
Quality control procedure for 6-[18F]fluoro-L-DOPA: a presynaptic PET imaging ligand for brain dopamine neuronsJ J Chen, S J Huang, R D Finn, et al.
Archives of General Psychiatry|May 1, 1987
L-deprenyl in Alzheimer's disease. Preliminary evidence for behavioral change with monoamine oxidase B inhibitionP N Tariot, R M Cohen, T Sunderland, et al.
The New England Journal of Medicine|June 13, 1996
Presynaptic dopaminergic deficits in Lesch-Nyhan diseaseM Ernst, A J Zametkin, J A Matochik, et al.
Archives of Neurology|January 1, 1994
Normal activation of frontotemporal language cortex in dyslexia, as measured with oxygen 15 positron emission tomographyJ M Rumsey, A J Zametkin, P Andreason, et al.
The American Journal of Psychiatry|August 1, 1988
A new scale for the assessment of depressed mood in demented patientsT Sunderland, I S Alterman, D Yount, et al.
Clinical Pharmacology and Therapeutics|March 1, 1997
Bromfenac disposition in patients with impaired kidney functionJ C Ermer, J P Boni, W H Cevallos, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1989
Reversal of brain metabolic abnormalities following treatment of AIDS dementia complex with 3'-azido-2',3'-dideoxythymidine (AZT, zidovudine): a PET-FDG studyA Brunetti, G Berg, G Di Chiro, et al.
Pageof 25

Showing results (221-230 of 245) with videos related to

Sort By:
Pageof 25
The Journal of Clinical Endocrinology and Metabolism|June 1, 1984
The metabolic effects of biosynthetic human proinsulin in individuals with type I diabetesR M Bergenstal, R M Cohen, E Lever, et al.
Biological Psychiatry|August 1, 1994
Right frontotemporal activation by tonal memory in dyslexia, an O15 PET StudyJ M Rumsey, P Andreason, A J Zametkin, et al.
The New England Journal of Medicine|October 20, 1994
Estrogen resistance caused by a mutation in the estrogen-receptor gene in a manE P Smith, J Boyd, G R Frank, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1989
Quality control procedure for 6-[18F]fluoro-L-DOPA: a presynaptic PET imaging ligand for brain dopamine neuronsJ J Chen, S J Huang, R D Finn, et al.
Archives of General Psychiatry|May 1, 1987
L-deprenyl in Alzheimer's disease. Preliminary evidence for behavioral change with monoamine oxidase B inhibitionP N Tariot, R M Cohen, T Sunderland, et al.
The New England Journal of Medicine|June 13, 1996
Presynaptic dopaminergic deficits in Lesch-Nyhan diseaseM Ernst, A J Zametkin, J A Matochik, et al.
Archives of Neurology|January 1, 1994
Normal activation of frontotemporal language cortex in dyslexia, as measured with oxygen 15 positron emission tomographyJ M Rumsey, A J Zametkin, P Andreason, et al.
The American Journal of Psychiatry|August 1, 1988
A new scale for the assessment of depressed mood in demented patientsT Sunderland, I S Alterman, D Yount, et al.
Clinical Pharmacology and Therapeutics|March 1, 1997
Bromfenac disposition in patients with impaired kidney functionJ C Ermer, J P Boni, W H Cevallos, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1989
Reversal of brain metabolic abnormalities following treatment of AIDS dementia complex with 3'-azido-2',3'-dideoxythymidine (AZT, zidovudine): a PET-FDG studyA Brunetti, G Berg, G Di Chiro, et al.
Pageof 25